Compare Stocks → Move Your Money Before May 22 (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison TSE:APSNYSE:FRXTSE:PLICVE:SNG Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPSAptose BiosciencesC$1.70+4.9%C$2.10C$1.59▼C$11.40C$26.71M1.449,266 shs32,400 shsFRXForest Road Acquisition$10.30$9.72▼$18.20$450MN/A2.07 million shs40,482 shsPLIProMetic Life SciencesC$13.60C$7.13▼C$590.00C$317.06MN/A8,002 shs921 shsSNGSilver Range ResourcesC$0.10+11.8%C$0.08C$0.06▼C$0.15C$9.02M-0.0330,953 shs1,500 shs7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPSAptose Biosciences-2.41%-7.43%-23.94%-38.64%+153.13%FRXForest Road Acquisition0.00%0.00%0.00%0.00%0.00%PLIProMetic Life Sciences0.00%0.00%0.00%0.00%0.00%SNGSilver Range Resources0.00%-5.00%+35.71%+35.71%-29.63%Move Your Money Before May 22 (Ad)The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPSAptose BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AFRXForest Road AcquisitionN/AN/AN/AN/AN/AN/AN/AN/APLIProMetic Life SciencesN/AN/AN/AN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPSAptose BiosciencesN/AN/AN/AN/AFRXForest Road AcquisitionN/AN/AN/AN/APLIProMetic Life SciencesN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPSAptose BiosciencesN/AN/AC$1.06 per share1.60C$1.03 per shareN/AFRXForest Road AcquisitionN/AN/AN/AN/A$0.56 per shareN/APLIProMetic Life SciencesC$39.91M0.00N/A3.94C$6.07 per share0.00SNGSilver Range ResourcesN/AN/AC$0.01 per share16.25C$0.11 per shareN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPSAptose Biosciences-C$51.21M-C$10.49N/A∞N/AN/A-225.00%-102.23%5/13/2024 (Estimated)FRXForest Road Acquisition-$7.92MN/A0.00N/AN/AN/AN/AN/AN/APLIProMetic Life SciencesN/A-C$63.06N/AN/AN/AN/AN/AN/AN/ASNGSilver Range Resources-C$1.69M-C$0.02N/A∞N/AN/A-16.23%-9.12%5/2/2024 (Estimated)Latest PLI, FRX, SNG, HZD, and APS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails3/26/2024Q4 2023APSAptose Biosciences-C$1.98-C$1.96+C$0.02-C$1.96N/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPSAptose BiosciencesN/AN/AN/AN/AN/AFRXForest Road AcquisitionN/AN/AN/AN/AN/APLIProMetic Life SciencesN/AN/AN/AN/AN/ASNGSilver Range ResourcesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPSAptose Biosciences14.270.785.41FRXForest Road AcquisitionN/A0.370.37PLIProMetic Life Sciences37.474.063.66SNGSilver Range Resources0.075.827.93OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPSAptose Biosciences9.80%FRXForest Road AcquisitionN/APLIProMetic Life SciencesN/ASNGSilver Range ResourcesN/AInsider OwnershipCompanyInsider OwnershipAPSAptose Biosciences20.20%FRXForest Road AcquisitionN/APLIProMetic Life SciencesN/ASNGSilver Range Resources38.33%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAPSAptose Biosciences3115.71 millionN/ANot OptionableFRXForest Road AcquisitionN/A37.50 millionN/ANot OptionablePLIProMetic Life Sciences48723.31 millionN/ANot OptionableSNGSilver Range ResourcesN/A94.97 millionN/ANot OptionablePLI, FRX, SNG, HZD, and APS HeadlinesSourceHeadlineWe'd forgotten quite how many Depeche Mode bargains Alan Wilder shifted in his legendary auctionmsn.com - April 26 at 9:44 AMThese are West Michigan's top 10 places to go birdingwzzm13.com - April 26 at 9:44 AMSilver Range Resources Ltd. to Present at Metals & Mining Virtual Investor Conference May 2ndfinance.yahoo.com - April 24 at 5:37 PMState Police Asking for Public’s Help Locating Suspect Vehicles in Fatal Pedestrian Hit-and-Run Crashtownsquaredelaware.com - April 23 at 4:34 PMGorgeous Anushka Sen Age, Height, Bio, Net Worth, Family, and More in 20240technosports.co.in - April 9 at 10:25 AMEndicott Business Owners Brace for Big Washington Avenue Projectwnbf.com - April 4 at 6:28 PMSilver Lake to Take Endeavor Privatetmcnet.com - April 2 at 3:22 PMOutdoors North: No lack of beautiful landscapes to visitminingjournal.net - March 29 at 4:43 PMBurlington Free Pressmsn.com - March 28 at 12:49 PMHow Quinta Brunson Hacked the Sitcomnewyorker.com - March 18 at 9:43 AMTwo Veteran Hikers Launch Seniq, an Outdoor Wear Line Catering to Womenmsn.com - March 14 at 7:20 PMOct. 7: Rape as an instrument of genocideclevelandjewishnews.com - March 13 at 3:00 PMReview: Ariana Grande isn’t perfect, and neither is ‘eternal sunshine’nyunews.com - March 13 at 9:59 AMThree Wyoming Authors Awarded Western Writing's Highest Honorcowboystatedaily.com - March 13 at 9:59 AMSkyfire, the Canberra Comedy Festival, and the Balloon Spectacular: 50+ things to do this weekhercanberra.com.au - March 11 at 8:29 PMWhat’s happening around New Mexico February 23-29msn.com - February 23 at 1:38 PMGame-changer for NJ beauty services: These are salon suites in New Jerseynj1015.com - February 21 at 4:33 PMTHIS UNIVERSITY OF FLORIDA PROGRAM OFFERS INSIGHTS INTO SUSTAINABLE LANDSCAPINGkeysweekly.com - February 21 at 4:33 PMTexas tough: Defense shines when offense struggles in virtual must-win over Kansas Statemsn.com - February 20 at 7:40 AMUMG Nashville Launches Silver Wings Records, Signs Huestonyahoo.com - February 15 at 6:02 PMDr. Jeremy Silver: Heart health risk factors to be aware ofwgnradio.com - February 4 at 2:52 PMMultiplayer Strategy Game “RoboHero” Featuring Seamless Integration of Tokens and NFTs to Launch on WEMIX PLAYmarkets.businessinsider.com - February 4 at 9:52 AMLocal Author's Book Available at Carson Tahoe Medical Center gift shopcarsonnow.org - February 4 at 9:52 AMCarson High School debate team shines at home tournamentcarsonnow.org - January 31 at 2:37 PMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesDelta Airline’s Put Option Activity Isn’t Bad NewsMarch 28, 2024 8:55 AMView Delta Airline’s Put Option Activity Isn’t Bad NewsWD-40 Company Greases the Wheels of Growth and ProfitsApril 10, 2024 10:12 AMView WD-40 Company Greases the Wheels of Growth and ProfitsCannabis: One Stock to Play the MovementApril 8, 2024 8:38 AMView Cannabis: One Stock to Play the Movement3 Technologies to Challenge NAND Flash Dominance in AI April 24, 2024 7:19 AMView 3 Technologies to Challenge NAND Flash Dominance in AI SMART Global Gets 25% Discount: Analysts Lift TargetsApril 11, 2024 10:21 AMView SMART Global Gets 25% Discount: Analysts Lift TargetsAll Headlines Company DescriptionsAptose BiosciencesTSE:APSAptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.Forest Road AcquisitionNYSE:FRXForest Road Acquisition Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the technology, media, and telecommunications space. The company was founded in 2020 and is based in New York, New York.ProMetic Life SciencesTSE:PLIPrometic Life Sciences Inc. operates as a biopharmaceutical company with two drug discovery platforms that focuses on unmet medical needs in the field of fibrosis and orphan diseases. Its product pipeline includes PBI-4050, an orally active lead drug candidate for fibrosis; plasminogen, a biopharmaceutical for the treatment of congenital plasminogen deficiency; and intravenous immunoglobulin, a preparation of antibodies purified from plasma donations from healthy individuals. The company was founded in 1992 and is based in Laval, Canada.Silver Range ResourcesCVE:SNGSilver Range Resources Ltd., a junior resource exploration company, engages in the acquisition, exploration, and evaluation of precious metal resources in Canada. The company explores for gold, silver, zinc, lead, and copper deposits. Its property portfolio comprises mineral properties located in Nevada, the Northwest Territories, Nunavut, and the Yukon Territory. Silver Range Resources Ltd. was incorporated in 2010 and is headquartered in Vancouver, Canada. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.